Salona Global Medical Device
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Salona Global Medical Device generated cash of -$918,908, which is more than the previous year. Cash used in financing activities reached the amount of $824,540 last year. Net change in cash is therefore -$1,009,786.
Cash Flow
| 2016 | -20.69M | -21.03K | 21.07M |
|---|---|---|---|
| 2018 | 3.07M | -92.81K | -2.45M |
| 2020 | -128.04K | -899.40K | 0 |
| 2021 | -975.17K | 74.87K | 5.43M |
| 2023 | -918.90K | -1.51M | 824.54K |
LNDZF Cash Flow Statement (2015 – 2023)
| 2023 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|
Cash at beginning of period | 1.92M | 8.34M | 9.30M | 5.94M | 9.09M |
Operating activities | |||||
Net income | -15.60M | -2.66M | -1.76M | -8.05M | -3.09M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 2.48M | 841.76K | 54.51K | 276.72K | 1.27K |
Stock-based compensation expense | 1.28M | 237.71K | 21.96K | 124.27K | 1.35M |
| Deferred income tax benefit | 1.28M | 237.71K | 21.96K | 124.27K | 1.35M |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | -1.90M | -2.06M | 0 | -2.13M | -18.37M |
Inventories | 4.64M | 248.44K | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -918.90K | -975.17K | -128.04K | 3.07M | -20.69M |
Investing activities | |||||
Purchases Of Investments | 0 | -370.23K | -899.40K | 0 | 0 |
Investments In Property Plant And Equipment | -203.26K | -55.25K | 0 | -92.81K | -21.03K |
Acquisitions Net | -1.31M | -5.05M | 0 | 0 | 0 |
Cash generated by investing activities | -1.51M | 74.87K | -899.40K | -92.81K | -21.03K |
Financing activities | |||||
Common Stock Issued | 0 | 4.26M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | -245.64K | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 790.63K | -2.53M | 0 | 0 | 0 |
Cash used in financing activities | 824.54K | 5.43M | 0 | -2.45M | 21.07M |
Net Change In Cash | -1.00M | 4.15M | -954.47K | 109.21K | 2.66M |
Cash at end of period | 918.67K | 12.50M | 8.34M | 6.05M | 11.75M |
| Data source |